<DOC>
	<DOCNO>NCT01373606</DOCNO>
	<brief_summary>This open-label , multi-center study , investigate efficacy safety terlipressin Japanese patient hepatorenal syndrome type 1 .</brief_summary>
	<brief_title>A Study Terlipressin Patients With Hepatorenal Syndrome Type 1</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hepatorenal Syndrome</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Patients diagnose HRS type 1 accord diagnostic criterion HRS whose serum creatinine value ( SCr ) double 2.5 mg/dL great within 2 week whose 24h creatinine clearance ( Ccr ) decrease half le 20 mL/min . Patients meet follow 5 criterion : [ Modified International Ascites Club 's Diagnostic criterion HRS ] 1 . Chronic acute liver disease advance hepatic failure portal hypertension . 2 . Low glomerular filtration rate ( SCr &gt; 1.5 mg/dL 24h Ccr &lt; 40 mL/min ) 3 . Absence shock , ongoing bacterial infection , current recent ( within 2 week ) treatment nephrotoxic drug 4 . No sustained improvement renal function ( decrease SCr 1.5 mg/dL less increase 24h Ccr 40 mL/min ) follow diuretic withdrawal expansion plasma volume 1,500 mL/24h isotonic saline 24 48h . 5 . Protein urea &lt; 500 mg/dL , ultrasonographic evidence obstructive uropathy parenchymal renal disease Age ; 20 79 year Cr value ≥5 mg/dL ChildPugh Score ≥14 Fulminant hepatitis Septic shock Hepatocellular carcinoma meet Milan Criteria Acute renal failure cause contrast medium Chronic renal failure Bradycardia ( heart rate &lt; 50/min ) Hyponatraemia ( serum Na &lt; 120 mEq/L ) Ischemic heart disease ( angina pectoris , myocardial infarction ) , heart failure clinically relevant arrhythmia Poorcontrolled hypertension Arteriosclerosis obliterans peripheral vascular disorder Cerebrovascular disorder Respiratory diseases chronic obstructive pulmonary disease Pregnant possibly pregnant woman patient whose partner desire pregnancy study period Patients consider investigator subinvestigator unsuitable participate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>